Ibio Inc (IBIO)
$2.20 0.02 (0.90%)
17:05 EDT IBIO Stock Quote Delayed 30 Minutes
Previous Close $2.22
Market Cap 35.07M
PE Ratio -1.29
Volume (Avg. Vol.) 11.23M
Day's Range 2.13 - 2.35
52-Week Range 0.05 - 3.40
Dividend & Yield N/A (N/A)
IBIO Stock Predictions, Articles, and Ibio Inc News
- From InvestorPlace
- From the Web
The reason I mentioned iBio’s addition to the indexes is that it shows how little investors really know about what’s happening behind the scenes at iBio’s vaccine central. There's a dearth of information available.
Asset prices don't go up in a straight line, even if the company shows promise. Use the dip in IBIO stock now to get in at a favorable price.
Fears of a second coronavirus wave have Covid-19 focused biotech stocks surging again. So where does IBIO stock fit into the mix?
Buying a stock because it could be part of the solution to coronavirus is a risky way to play an already volatile market. IBIO stock's weak financials make it all the more dependent on coronavirus drugs to deliver.
IBIO stock is on a bull run of epic proportions but there is little to suggest the biotech company can come up with a Covid-19 vaccine.
iBio stock is still a buy but it needs to land contracts with some major vaccine developers as we get closer to a Covid-19 vaccine
By Alex Sirois
IBIO stock has drawn a good deal of interest of late. It's a speculative play with the potential to reward optimistic investors handsomely.
The enthusiasm surrounding iBio stock is warranted since the company is yet to deliver a viable, commercially successful vaccine.
Unlike other vaccine stocks, iBio has the tech it needs to scale up manufacturing of its candidate. That makes IBIO stock a buy here.
For investors in search of a novel coronavirus play, IBIO’s puny capitalization and continued one-trick pony press releases are fair warning and, increasingly, so is the price chart.
By Ian Cooper
The price of iBio stock could double, if not triple in value on successful trials, and on the potential for FDA approval in the near term.
These seven A- and B-rated names are some of the top risky stocks to buy for enterprising investors. Here's what you should know about each company.
With the underlying vaccination business, IBIO stock could make you rich. At the same time, if things go awry, it could make you poor in a hurry.
iBio's production facility could be used to manufacture a Covid-19 vaccine. It remains to be seen if IBIO stock will be a star or a bust.
IBIO stock is hardly alone as a direct play on the coronavirus vaccine industry. Nevertheless, the company separates itself from the muck with its proprietary ability to scale up solutions.
A bet on IBIO stock is a bet on its plant-based research and its FastPharming processes. IBIO is one of the hottest stocks for good reason.
By Thomas Niel
Don't bet the ranch, but consider these five high-risk micro-cap stocks a buy, as each one has the potential for big gains.
Every investor is betting on a vaccine. Unfortunately, the case for IBIO stock is simply too speculative, as its trials remain under wraps.
Why It Might Not Make Sense To Buy American Financial Group, Inc. (NYSE:AFG) For Its Upcoming Dividend
American Financial Group, Inc. (NYSE:AFG) is about to trade ex-dividend in the next three days. You can purchase shares before the 14th of July in order to receive the dividend,<div><a class="permalink" href="https://simplywall.st/stocks/us/insurance/nyse-afg/american-financial-group/news/why-it-might-not-make-sense-to-buy-american-financial-group-inc-nyseafg-for-its-upcoming-dividend/">Read More...</a></div>
Stephen Lindner has been the CEO of American Financial Group, Inc. (NYSE:AFG) since 2005, and this article will examine the executive’s compensation with respect to the overall performance of the<div><a class="permalink" href="https://simplywall.st/stocks/us/insurance/nyse-afg/american-financial-group/news/how-is-american-financial-groups-nyseafg-ceo-paid-relative-to-peers/">Read More...</a></div>
AF Gruppen’s’s (OB:AFG) stock is up by a considerable 33% over the past three months. As most would know, fundamentals are what usually guide market price movements over the long-term,<div><a class="permalink" href="https://simplywall.st/stocks/no/capital-goods/ob-afg/af-gruppen-shares/news/af-gruppen-asas-obafg-stock-is-going-strong-have-financials-a-role-to-play/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader